KDM4A and acute myeloid leukemia: It has also been reported that the inhibition or downregulation of KDM4A causes a decrease in the proliferation of acute myeloid leukemia (Massett et al., 2021), breast cancer (Metzger et al., 2017), and prostate cancer (Mu et al., 2019).